These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10188730)
61. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma. Lovat PE; Corazzari M; Di Sano F; Piacentini M; Redfern CP Cancer Lett; 2005 Oct; 228(1-2):105-10. PubMed ID: 15907365 [TBL] [Abstract][Full Text] [Related]
62. Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles. Okuda T; Kawakami S; Higuchi Y; Satoh T; Oka Y; Yokoyama M; Yamashita F; Hashida M Int J Pharm; 2009 May; 373(1-2):100-6. PubMed ID: 19429294 [TBL] [Abstract][Full Text] [Related]
63. Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin. Honsik CJ; Jung G; Reisfeld RA Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7893-7. PubMed ID: 3094017 [TBL] [Abstract][Full Text] [Related]
64. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells. Herbert BS; Sanders BG; Kline K Nutr Cancer; 1999; 34(2):121-32. PubMed ID: 10578478 [TBL] [Abstract][Full Text] [Related]
65. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130 [TBL] [Abstract][Full Text] [Related]
66. Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes. Kushner BH; Cheung NK Cancer Res; 1991 Sep; 51(18):4865-70. PubMed ID: 1654202 [TBL] [Abstract][Full Text] [Related]
67. [Inhibitory effects on hepatocarcinoma and B16 melanoma cells by N-(4-hydrophenyl) retinamide]. Zhang L; Wu XZ Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):421-7. PubMed ID: 14724932 [TBL] [Abstract][Full Text] [Related]
68. Analysis of a murine anti-ganglioside GD2 monoclonal antibody expressing both IgG2a and IgG3 isotypes: monoclonality, apoptosis triggering, and activation of cellular cytotoxicity on human melanoma cells. Lin CC; Shen YC; Chuang CK; Liao SK Adv Exp Med Biol; 2001; 491():419-29. PubMed ID: 14533812 [TBL] [Abstract][Full Text] [Related]
70. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells. Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839 [TBL] [Abstract][Full Text] [Related]
71. 64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanoma. Vavere AL; Butch ER; Dearling JL; Packard AB; Navid F; Shulkin BL; Barfield RC; Snyder SE J Nucl Med; 2012 Nov; 53(11):1772-8. PubMed ID: 23064212 [TBL] [Abstract][Full Text] [Related]
72. Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2. Sen G; Chakraborty M; Foon KA; Reisfeld RA; Bhattacharya-Chatterjee M Clin Cancer Res; 1997 Nov; 3(11):1969-76. PubMed ID: 9815586 [TBL] [Abstract][Full Text] [Related]
73. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells. Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814 [TBL] [Abstract][Full Text] [Related]
74. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody. Pan H; Niu GQ; Pan J; Lu WY Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823 [TBL] [Abstract][Full Text] [Related]
75. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide. Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458 [TBL] [Abstract][Full Text] [Related]
76. PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD Siebert N; Zumpe M; Jüttner M; Troschke-Meurer S; Lode HN Oncoimmunology; 2017; 6(10):e1343775. PubMed ID: 29123953 [TBL] [Abstract][Full Text] [Related]
77. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer. Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399 [TBL] [Abstract][Full Text] [Related]
78. Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells. Wierzbicki A; Gil M; Ciesielski M; Fenstermaker RA; Kaneko Y; Rokita H; Lau JT; Kozbor D J Immunol; 2008 Nov; 181(9):6644-53. PubMed ID: 18941255 [TBL] [Abstract][Full Text] [Related]
79. Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment. Bruno S; Tenca C; Saverino D; Ciccone E; Grossi CE Carcinogenesis; 2002 Mar; 23(3):447-56. PubMed ID: 11895859 [TBL] [Abstract][Full Text] [Related]
80. Targeted delivery to neuroblastoma of novel siRNA-anti-GD2-liposomes prepared by dual asymmetric centrifugation and sterol-based post-insertion method. Adrian JE; Wolf A; Steinbach A; Rössler J; Süss R Pharm Res; 2011 Sep; 28(9):2261-72. PubMed ID: 21594716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]